These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2698 related articles for article (PubMed ID: 7512644)

  • 41. Phosphorothioate oligonucleotides reduce melanoma growth in a SCID-hu mouse model by a nonantisense mechanism.
    Jansen B; Wadl H; Inoue SA; Trülzsch B; Selzer E; Duchêne M; Eichler HG; Wolff K; Pehamberger H
    Antisense Res Dev; 1995; 5(4):271-7. PubMed ID: 8746776
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interleukin-1-mediated H2O2 production by hepatic sinusoidal endothelium in response to B16 melanoma cell adhesion.
    Anasagasti MJ; Alvarez A; Avivi C; Vidal-Vanaclocha F
    J Cell Physiol; 1996 May; 167(2):314-23. PubMed ID: 8613473
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical evaluation of metastases of malignant melanoma imaging with 99Tcm-glutathione and 99Tcm-anti-melanoma antibody: a comparative study.
    Duman Y; Burak Z; Ercan MT; Dirlik A; Bilkay BC; Akin Y; Taner M; Bekdik CF
    Nucl Med Commun; 1995 Nov; 16(11):927-35. PubMed ID: 8587759
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of melanoma cell/matrix interaction by tamoxifen.
    Mac Neil S; Wagner M; Kirkham PR; Blankson EA; Lennard MS; Goodall T; Rennie IG
    Melanoma Res; 1993 Feb; 3(1):67-74. PubMed ID: 8471839
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stability analysis of latent and active 72-kDa type IV collagenase: the role of tissue inhibitor of metalloproteinases-2 (TIMP-2).
    Kleiner DE; Tuuttila A; Tryggvason K; Stetler-Stevenson WG
    Biochemistry; 1993 Feb; 32(6):1583-92. PubMed ID: 8431437
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A case of superficial spreading melanoma in situ 2.5 mm in diameter.
    Ban M; Yoneda K; Yanagihara M; Mori S; Seko T
    J Dermatol; 1993 Jul; 20(7):432-5. PubMed ID: 8408926
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reversible inhibition of growth of B16 melanoma cells by decreased amino acid nutrition.
    Korohoda W; Michalik M; Zaporowska-Siwiak E
    Folia Histochem Cytobiol; 1993; 31(2):67-70. PubMed ID: 8405570
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changes in plasma 5-S-cysteinyldopa concentration in B16 melanoma-bearing mice treated with interferon-beta or dacarbazine.
    Hasegawa K; Inoue S; Wakamatsu K; Ito S; Fujita K; Ishihara K
    Melanoma Res; 1993 Oct; 3(5):377-80. PubMed ID: 8292896
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Preoperative ultrasonographic measurement of melanoma thickness with 20 MHz probe].
    Pennasilico G; Santini A; Bono R; Cacciaguerra MG; Puddu P; Falappa P
    Radiol Med; 1994 Oct; 88(4):388-91. PubMed ID: 7997609
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intrinsic and extrinsic characteristics of human tumors relevant to radiosurgery: comparative cellular radiosensitivity and hypoxic percentages.
    Leith JT; Cook S; Chougule P; Calabresi P; Wahlberg L; Lindquist C; Epstein M
    Acta Neurochir Suppl; 1994; 62():18-27. PubMed ID: 7717130
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DNA repair and repair fidelity in metastatic variants of the B16 murine melanoma.
    Usmani BA; Lunec J; Sherbet GV
    J Cell Biochem; 1993 Mar; 51(3):336-44. PubMed ID: 7684740
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Radiosensitizer AK-2123 as modulating agent in the chemotherapy of experimental metastases.
    Konovalova NP; Diatchkovskaya RF; Volkova LM; Kagiya TV
    Neoplasma; 1995; 42(3):119-22. PubMed ID: 7637820
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Suppression of lung metastasis of B16 mouse melanoma cells by introduction of N-acetylglucosaminyltransferase III gene].
    Yoshimura M; Taniguchi N
    Nihon Rinsho; 1995 Jul; 53(7):1786-90. PubMed ID: 7630020
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The release of TNF-alpha (factor) by peritoneal macrophages of hamsters bearing transplantable melanomas.
    Kozłowska K; Cichorek M
    Neoplasma; 1995; 42(2):75-8. PubMed ID: 7617080
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structure-activity relationships of phenyl- and benzoylpyrroles.
    Laatsch H; Renneberg B; Hanefeld U; Kellner M; Pudleiner H; Hamprecht G; Kraemer HP; Anke H
    Chem Pharm Bull (Tokyo); 1995 Apr; 43(4):537-46. PubMed ID: 7600609
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of selected strongly and weakly invasive sublines of a primary human melanoma cell line and isolation of subtractive cDNA clones.
    Jacob K; Bosserhoff AK; Wach F; Knüchel R; Klein EC; Hein R; Buettner R
    Int J Cancer; 1995 Mar; 60(5):668-75. PubMed ID: 7532159
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of Ku autoantigen binding activity to the E2F motif after ultraviolet B irradiation of melanocytic cells.
    Pedley J; Pettit A; Parsons PG
    Melanoma Res; 1998 Dec; 8(6):471-81. PubMed ID: 9918408
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Extension of useful reagent shelf life beyond manufacturers' recommendations. Cell Markers Committee of the College of American Pathologists.
    Tubbs RR; Nagle R; Leslie K; Pettigrew NM; Said JW; Corwin DJ; Rickert RR; Roche PC
    Arch Pathol Lab Med; 1998 Dec; 122(12):1051-2. PubMed ID: 9870851
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High doses of thymosin alpha 1 enhance the anti-tumor efficacy of combination chemo-immunotherapy for murine B16 melanoma.
    Pica F; Fraschetti M; Matteucci C; Tuthill C; Rasi G
    Anticancer Res; 1998; 18(5A):3571-8. PubMed ID: 9858941
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential response of human melanoma and Ehrlich ascites cells in vitro to the ribosome-inactivating protein luffin.
    Poma A; Miranda M; Spanò L
    Melanoma Res; 1998 Oct; 8(5):465-7. PubMed ID: 9835461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 135.